METHODS: A prospective study was designed to consist of an online survey. It was distributed to 135 African otolaryngologists. Questions focussed on HPV vaccination programmes; whether they were government directed; and their rollout. Information from countries that had multiple otolaryngologists respond to the survey were compared. Additionally, data review and corroboration were performed.
RESULTS: There were 58 (43%) participants from 19 countries. Nine countries reported a national vaccination programme (NVP), five used Cervarix; four used quadrivalent Gardasil. Collateral data revealed 18 of 54 countries had NVP in Africa and 26 countries had completed HPV vaccine pilot or demonstration projects.
CONCLUSIONS: HPV vaccination in Africa should be urgently re-evaluated to include the HPV-6 and HPV-11 strains that cause JORRP, which have not been recognised during national vaccination programme planning.
方法:一项前瞻性研究由在线调查组成。它分发给135名非洲耳鼻喉科医生。问题集中在HPV疫苗接种计划;它们是否是政府指导的;以及它们的推出。比较了来自多个耳鼻喉科医师对调查做出回应的国家的信息。此外,进行了数据回顾和确证.
结果:来自19个国家的58名(43%)参与者。九个国家报告了国家疫苗接种计划(NVP),五个使用了Cervarix;四个使用了四价Gardasil。附带数据显示,54个国家中有18个在非洲有NVP,26个国家已经完成了HPV疫苗试点或示范项目。
结论:应紧急重新评估非洲的HPV疫苗接种,以包括引起JORRP的HPV-6和HPV-11菌株,在国家疫苗接种计划规划中没有得到承认。